Lombard Odier Asset Management (USA)’s Teva Pharmaceuticals TEVA Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,000,000	Closed	-$9.74M	–	424
2021 Q3	$9.74M	Hold	1,000,000	–	–	0.43%	42
2021 Q2	$9.9M	Hold	1,000,000	–	–	0.39%	52
2021 Q1	$11.5M	Hold	1,000,000	–	–	0.42%	38
2020 Q4	$9.65M	Sell	1,000,000 -207,500	-17%	-$1.99M	0.46%	45
2020 Q3	$10.9M	Hold	1,207,500	–	–	0.71%	25
2020 Q2	$14.9M	Hold	1,207,500	–	–	1.04%	14
2020 Q1	$10.8M	Hold	1,207,500	–	–	1.13%	28
2019 Q4	$11.8M	Buy	+1,207,500	New	+$10.8M	1.06%	26
2018 Q3	–	Sell	-800,000	Closed	-$19.5M	–	299
2018 Q2	$19.5M	Buy	800,000 +60,000	+8%	+$1.22M	1.27%	15
2018 Q1	$12.6M	Buy	+740,000	New	+$14.4M	0.91%	35

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s TEVA Position: Q4 2019 in Review

Lombard Odier Asset Management (USA) sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 28,443 shares — an estimated $254K sold.

Lombard Odier Asset Management (USA) first reported a position in TEVA in Q3 2019 and held it in 1 quarter. The position peaked at $196K in Q3 2019. 437 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

Lombard Odier Asset Management (USA) reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 28,443 Teva Pharmaceuticals shares in Q4 2019, an estimated $254K.
Lombard Odier Asset Management (USA) first reported a position in Teva Pharmaceuticals in Q3 2019 and held it in 1 quarter.
Lombard Odier Asset Management (USA)'s Teva Pharmaceuticals position peaked at $196K in Q3 2019.
437 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2019, filed 14 Feb 2020.